Vamstar is a leading AI-powered global B2B healthcare supply chain platform, utilizing Machine Learning to capture the demand for MedTech and Pharmaceutical products and services from over 86,000 buyers in 100+ countries. The platform then matches this demand across its entire supplier base, offering improved transaction processes, real-time market insights, better sourcing programs, and the integration of ERP, CRM, and other systems for full supply chain visibility. With a presence in the United Kingdom, India, UAE, Netherlands, and the USA, Vamstar connects pharmaceutical and medical device companies with public and private buyers, including corporates, clinics, hospitals, health insurance companies, and Group Purchasing Organisations (GPOs). Founded in 2019, Vamstar recently secured a significant £6.46M Series A investment on June 22, 2022, facilitated by Alpha Intelligence Capital, Antler, b2venture, and DFF (Dutch Founders Fund). The company's platform offers promising potential in revolutionizing the healthcare supply chain industry, catering to the growing demand for innovative solutions in AI, Analytics, and Marketplaces.
Funding Stage | Amount | No. Investors | Investors | Date |
---|---|---|---|---|
Series A | £6.46M | 4 | DFF (Dutch Founders Fund) | 22 Jun 2022 |
Grant | Unknown | 1 | 30 Nov 2021 | |
Seed Round | $1.70M | 3 | 04 Feb 2021 | |
Grant | Unknown | 1 | 29 Jan 2021 | |
Grant | Unknown | 1 | 17 Dec 2020 |
No recent news or press coverage available for Vamstar.